Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC [Phase 2]
Phase 2 clinical trial evaluating BL-B01D1 in combination with Almonertinib for resectable EGFR-positive stage II-IIIB non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Pemetrexed and Carboplatin With or Without Anlotinib Hydrochloride for Osimertinib-resistant Non-squamous NSCLC [Phase 2]
Phase 2 clinical trial at Fudan University evaluating pemetrexed and carboplatin with or without anlotinib for osimertinib-resistant non-squ…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)
Clinical update on the OCTOPUS trial evaluating treatment for patients with BRAF V600E-mutant metastatic non-small cell lung cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
NuCana plc announced termination of a Phase 1/2 trial evaluating NUC-3373 in combination with other agents for patients with advanced solid …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy
This update presents the first real-world data on the use of durvalumab after chemoradiotherapy in patients with unresectable stage III non-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating early switch of a chemotherapy doublet versus four cycles of chemotherapy in advanced non-small cell lung cancer ha…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial ELVN-002 for HER2-mutant non-small cell lung cancer and HER2-positive metastatic breast cancer is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of focused ultrasound ablation with PD-1 antibody blockade in advanced solid tumors has been termin…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer [Phase 2]
This Phase 2 trial studied the combination of ramucirumab and pembrolizumab in EGFR-mutant recurrent or metastatic non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial of intratumoral gene-mediated cytotoxic immunotherapy for resectable non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors [Phase 2]
Telix's phase 2 trial of the CAIX-targeting PET tracer 89Zr-girentuximab in CAIX-positive solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) [Phase 1]
A Phase 1 clinical trial evaluating TG6050 for metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Lapatinib Plus Trametinib in KRAS Mutant NSCLC [Phase 1, Phase 2]
Phase 1/2 trial results assess the combination of lapatinib and trametinib in KRAS-mutant cancers, including colorectal cancer and non-small…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC [NA]
A completed clinical trial evaluated the efficacy of combining Argon-Helium Cryoablation with PD-1 inhibitors in non-small cell lung cancer.…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluates the combination of dacomitinib and PD-0325901 in advanced KRAS-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial (CHIO3) is evaluating chemotherapy combined with an immune checkpoint inhibitor for operable stage IIIA/IIIB non-small cell …
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
A clinical trial update indicates the SNP study ICORG 08-40, Version 4, sponsored by Cancer Trials Ireland, for colorectal cancer and non-sm…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer [Phase 2]
Phase II trial comparing SHR-1210 (camrelizumab) plus apatinib vs pemetrexed plus carboplatin in KRAS-mutant stage IV non-squamous non-small…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3 [Phase 2]
Phase 2 platform trial evaluating novel regimens versus standard of care in non-small cell lung cancer (NSCLC), Sub-study 3, has completed w…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC [Phase 3]
Phase 3 trial evaluating low-dose nivolumab in combination with chemotherapy versus standard chemotherapy as first-line treatment for advanc…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: [18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients [EARLY_Phase 1]
The document reports results from an early Phase 1 trial evaluating the [18F]F-AraG total-body PET imaging agent in healthy subjects and pat…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA NSCLC [Phase 2]
Describes a Phase 2 trial of PANK-003 cell injection with standard adjuvant chemotherapy for stage IIIA non-small cell lung cancer, with the…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study to Investigate LYL845 in Adults With Solid Tumors [Phase 1]
Lyell Immunopharma reports termination of the Phase 1 trial evaluating LYL845 in adults with solid tumors, including melanoma, non-small cel…